RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
interleukin 2 receptor, alpha
The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. [provided by RefSeq]
|
|
|
||
|---|---|---|---|
| Superior cervical ga… |
100
|
||
| Parietal lobe |
94
|
||
| T lymphocyte |
94
|
||
| Trigeminal ganglion |
93
|
||
| Salivary gland |
90
|
||
| Substantia nigra |
87
|
|
|
|
||
|---|---|---|---|
| Ontak |
100
|
||
| Simulect |
100
|
||
| Dacliximab |
100
|
||
| Proleukin (tn) |
99
|
||
| Staph Enterotoxin B |
71
|
||
| Baker's Yeast (sacch… |
59
|
Individual Studies |
|
|---|---|
|
|
Authors: Calliope A Dendrou, Vincent Plagnol, Erik Fung, Jennie H M Yang, Kate Downes, Jason D Cooper, Sarah Nutland, Gillian Coleman, Matthew Himsworth, Matthew Hardy,…
Nature genetics 2009 SepAuthors: Christopher E Lowe, Jason D Cooper, Todd Brusko, Neil M Walker, Deborah J Smyth, Rebecca Bailey, Kirsi Bourget, Vincent Plagnol, Sarah Field, Mark Atkinson,…
Nature genetics 2007 SepThought leaders and organizations working on research involving IL2RA.
conditions: Multiple Sclerosis
interventions: Zenapax
conditions: Multiple Sclerosis, Relapsing-Remitting
interventions: Daclizumab